Skip to main content

and
  1. Article

    Open Access

    The Activity of Crizotinib in Chemo-Refractory MET-Amplified Esophageal and Gastric Adenocarcinomas: Results from the AcSé-Crizotinib Program

    The AcSé-crizotinib program provides extensive screening of crizotinib-targeted genomic alteration in several malignancies. We here report the results in patients with esogastric MET-amplified adenocarcinomas.

    Thomas Aparicio, Nathalie Cozic, Christelle de la Fouchardière in Targeted Oncology (2021)

  2. Article

    Radiology and nuclear medicine: advancing together in the era of precision medicine

    Arturo Chiti, Yves Menu in European Journal of Nuclear Medicine and Molecular Imaging (2020)

  3. No Access

    Article

    Splenic and portal venous obstruction in chronic pancreatitis

    The aim of this study was a prospective search for splenoportal venous obstruction (SPVO) in a medical-surgical series of 266 patients with chronic pancreatitis who were followed up a mean time of 8.2 years. S...

    Pr. Pierre Bernades, André Baetz, Philippe Lévy in Digestive Diseases and Sciences (1992)